Presentation TCT 2024 TCT 299: Cangrelor Use in Acute Myocardial Infarction Patients Awaiting Coronary Artery Bypass Grafting Presenter: Jennifer Rymer October 29, 2024
Presentation TCT 2024 TCT 784: Gender Disparities in Cangrelor Outcomes for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Presenter: Waiel Abusnina October 29, 2024
Presentation TCT 2024 TCT 174: High Bleeding Risk and Outcomes in Acute Coronary Syndrome After Percutaneous Coronary Intervention With Versus Without Cangrelor Presenter: Patrick Creechan October 28, 2024
Presentation TCT 2024 TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study Presenter: Angelo Oliva October 27, 2024
Presentation TCT 2024 TCT 1: Differential Outcomes in ST-Elevation and Non-ST Elevation Myocardial Infarction Outcomes After Percutaneous Coronary Intervention With Versus Without Cangrelor Presenter: Andrew Hill October 27, 2024
Presentation TCT 2024 TCT 1351: Cangrelor in a Challenging Scenario of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI Presenter: Federico Oliveri October 27, 2024
Presentation TCT 2024 TCT 238: Safety and Efficacy of Cangrelor: A Multicenter Nationwide Registry ARECA (Austrian Registry for Cangrelor Application) Presenter: Guy Friedrich October 27, 2024
Presentation TCT 2024 TCT 236: Bailout Use of Cangrelor During Percutaneous Coronary Intervention and Associated Inpatient Outcomes Presenter: Abhishek Chaturvedi October 27, 2024